Works matching IS 14642662 AND DT 2007 AND VI 8 AND IP 4

Results: 11

A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl l-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection.
Published in:
2007
By:
- Youle M;
- Osio M;
- ALCAR Study Group
Publication type:
Journal Article
Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
Published in:
2007
By:
- Laurichesse J;
- Persoz A;
- Theodorou I;
- Rouzioux C;
- Delfraissy J;
- Meyer L
Publication type:
Journal Article
Multivitamin supplementation in HIV-positive pregnant women: impact on depression and quality of life in a resource-poor setting.
Published in:
HIV Medicine, 2007, v. 8, n. 4, p. 203, doi. 10.1111/j.1468-1293.2007.00454.x
By:
- Smith Fawzi, M. C.;
- Kaaya, S. F.;
- Mbwambo, J.;
- Msamanga, G. I.;
- Antelman, G.;
- Wei, R.;
- Hunter, D. J.;
- Fawzi, W. W.
Publication type:
Article
Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Δ32 deletion.
Published in:
HIV Medicine, 2007, v. 8, n. 4, p. 213, doi. 10.1111/j.1468-1293.2007.00455.x
By:
- Laurichesse, J. J.;
- Persoz, A.;
- Theodorou, I.;
- Rouzioux, C.;
- Delfraissy, J. F.;
- Meyer, L.
Publication type:
Article
Concomitant use of gastric acid-reducing agents is frequent among HIV-1-infected patients receiving protease inhibitor-based highly active antiretroviral therapy.
Published in:
HIV Medicine, 2007, v. 8, n. 4, p. 220, doi. 10.1111/j.1468-1293.2007.00456.x
By:
- van Lunzen, J.;
- Liess, H.;
- Arastéh, K.;
- Walli, R.;
- Daut, B.;
- Schürmann, D.
Publication type:
Article
Seroprevalence of HIV infection in hospitalized paediatric patients at a tertiary care centre in western India.
Published in:
2007
By:
- Shah, I.;
- Katira, B.
Publication type:
Letter
Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study.
Published in:
HIV Medicine, 2007, v. 8, n. 4, p. 226, doi. 10.1111/j.1468-1293.2007.00464.x
By:
- Mallolas, J.;
- Blanco, J. L.;
- Labarga, P.;
- Vergara, A.;
- Ocampo, A.;
- Sarasa, M.;
- Arnedo, M.;
- López-Púa, Y.;
- García, J.;
- Juega, J.;
- Guelar, A.;
- Terrón, A.;
- Dalmau, D.;
- García, I.;
- Zárraga, M.;
- Martínez, E.;
- Carn, X.;
- Pumarola, T.;
- Escayola, R.;
- Gatell, J. M.
Publication type:
Article
Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials.
Published in:
HIV Medicine, 2007, v. 8, n. 4, p. 259, doi. 10.1111/j.1468-1293.2007.00465.x
By:
- Hill, A.;
- Moyle, G.
Publication type:
Article
Prediction of clinical benefits of ritonavir-boosted TMC114 from treatment effects on CD4 counts and HIV RNA.
Published in:
HIV Medicine, 2007, v. 8, n. 4, p. 234, doi. 10.1111/j.1468-1293.2007.00466.x
By:
- Hill, A.;
- Montaner, J.;
- Smith, C.
Publication type:
Article
A double-blind, parallel-group, placebo-controlled, multicentre study of acetyll-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection.
Published in:
HIV Medicine, 2007, v. 8, n. 4, p. 241, doi. 10.1111/j.1468-1293.2007.00467.x
By:
- Youle, M.;
- Osio, M.
Publication type:
Article
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
Published in:
HIV Medicine, 2007, v. 8, n. 4, p. 251, doi. 10.1111/j.1468-1293.2007.00468.x
By:
- Martínez, E.;
- Milinkovic, A.;
- Buira, E.;
- de Lazzari, E.;
- León, A.;
- Larrousse, M.;
- Lonc, M.;
- Laguno, M.;
- Blanco, J. L.;
- Mallolas, J.;
- García, F.;
- Mir, J. M.;
- Gatell, J. M.
Publication type:
Article